Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug 13;24(1):500.
doi: 10.1186/s13054-020-03228-3.

High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection

Adriana Françozo de Melo  1 , Mauricio Homem-de-Mello  2
Affiliations
Comment

High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection

Adriana Françozo de Melo et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Comment on

References

    1. Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21:300. doi: 10.1186/s13054-017-1891-y. - DOI - PMC - PubMed
    1. Du W-D, Yuan Z-R, Sun J, Tang J-X, Cheng A-Q, Shen D-M, et al. Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol. 2003;9:2565–2569. doi: 10.3748/wjg.v9.i11.2565. - DOI - PMC - PubMed
    1. The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19 — preliminary report. N Engl J Med. 2020:1–11. 10.1056/NEJMoa2021436. - PubMed
    1. Carr AC. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Crit Care. 2020;24:133. doi: 10.1186/s13054-020-02851-4. - DOI - PMC - PubMed
    1. Hernández A, Papadakos PJ, Torres A, González DA, Vives M, Ferrando C, et al. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19 TT - Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19. Rev Esp Anestesiol Reanim. 2020;67:245–252. doi: 10.1016/j.redar.2020.03.004. - DOI - PMC - PubMed

LinkOut - more resources